AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 1st, 2018 • Flex Pharma, Inc. • Pharmaceutical preparations • Massachusetts
This AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (the “Amendment”) between Flex Pharma, Inc., a Delaware corporation (the “Company”), and John McCabe (the “Executive”) is effective as of June 20, 2018 (the “Effective Date”). Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Employment Agreement (as defined below).
FLEX PHARMA, INC. ADVISOR AGREEMENT Date: June 26, 2018Advisor Agreement • August 1st, 2018 • Flex Pharma, Inc. • Pharmaceutical preparations • Massachusetts
This Advisor Agreement (this “Agreement”), effective as of the date written above (the “Effective Date”), is between Flex Pharma, Inc., a Delaware corporation (the “Company”), and Thomas Wessel (“Advisor”).
Re: Separation Agreement Dear Tom:Separation Agreement • August 1st, 2018 • Flex Pharma, Inc. • Pharmaceutical preparations • Massachusetts
This Separation Agreement constitutes notice, including, but not limited to notice under Section 10(d) of your Executive Employment Agreement dated December 23, 2014, as amended on May 27, 2015 and January 8, 2018 (“Employment Agreement”), that your employment with Flex Pharma Inc. (along with its affiliates, the “Company”) will terminate on June 26, 2018. This Separation Agreement sets forth the understanding between you and the Company relating to the termination of your employment with the Company effective on June 26, 2018. We hope to make the transition as smooth as possible.
